Atenolol Tablets BP 50 mg Exporter in India – Healthy Inc

Atenolol Tablets BP 50 mg | Exporter
Product image for Atenolol Tablets BP 50 mg Exporter; regulatory dossiers & international shipping.
Product Information
| Generic Name | Atenolol |
|---|---|
| Manufacturer | Healthy Life Pharma Pvt. Ltd. |
| HSN Code | 30049074 |
| Pharmacopoeia | BP |
| Product Type | Tablet |
| Category | Antihypertensive drugs – Beta Blocker |
| Subcategory | Beta Blocker |
| Active Ingredient | Atenolol |
| Strength | 50 mg |
| Dosage Form | Tablet |
| Pack Size | 10 x 10 Tablets / Box (Alu-Alu / Blister) |
| Route of Administration | Oral |
| Prescription Required | Yes |
| Therapeutic Category | Antihypertensive drugs – Beta Blocker |
Medicine Details & Safety
| Short Description | Healthy Inc invites international procurement enquiries for Atenolol Tablets BP 50 mg manufactured by Healthy Life Pharma. Importers and overseas distributors can submit destination-country requirements for assessment of registration documentation, export artwork and shipment feasibility. | ||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Approved Uses / Indications | 1. First-line management of mild, moderate, and severe essential hypertension. 2. Adjunctive treatment in chronic stable angina pectoris and reduction of cardiovascular mortality. | ||||||||||||||||||||||||
| Full Description | Healthy Inc invites international procurement enquiries for Atenolol Tablets BP 50 mg manufactured by Healthy Life Pharma. Importers and overseas distributors can submit destination-country requirements for assessment of registration documentation, export artwork and shipment feasibility. Product technical specifications
Product technical specifications
Export regulatory and dossier readinessIdentify the destination authority and registration pathway. Request confirmation of CTD or ACTD dossier availability, COPP, Free Sale Certificate and current GMP documentation as applicable. Confirm COA and analytical files for the proposed product and market.Climatic zone stability and export artworkFor Atenolol Tablets BP 50 mg, request stability evidence appropriate to the importing market, including Zone IVb where required. Confirm shelf life, storage conditions and multilingual carton, blister and leaflet artwork against approved documentation.Global logistics and trade termsSpecify the destination, shipment size and required delivery window. Evaluate air freight or LCL/FCL sea freight from Mumbai where feasible. Agree EXW, FOB, CIF or CIP as appropriate to the transport mode and contract; confirm freight, insurance and customs responsibilities.International buyer requirementsEnquiries may identify Africa, LATAM, Middle East, CIS or APAC as target regions. Market authorization, import permits, document availability and shipment acceptance must be confirmed for each country; this is not a statement of existing registrations. | ||||||||||||||||||||||||
| Dosage Instructions | Administer orally once or twice daily at the same time each day, with or without food. Do not discontinue abruptly; gradual downward titration is recommended under medical supervision. | ||||||||||||||||||||||||
| Side Effects | Common: Peripheral edema (ankle swelling), dizziness, headache, flushing, fatigue. Uncommon: Postural hypotension, palpitations, dyspepsia, dry cough, muscle cramps. Rare: Bradycardia, severe hypotension, syncope, hyperkalemia, angioedema. | ||||||||||||||||||||||||
| Warnings and Precautions | Hypotension Monitoring: Monitor seated blood pressure during initial titration. Electrolyte Balance: Periodically verify serum potassium and renal clearance in patients with underlying renal insufficiency. Heart Failure Caution: Use with careful clinical assessment in heart failure patients. | ||||||||||||||||||||||||
| Contraindications | 1. Hypersensitivity to Atenolol or related cardiovascular agent classes. 2. Severe cardiogenic shock, second- or third-degree atrioventricular block without a pacemaker. 3. Clinically severe hypotension (systolic BP < 90 mmHg). 4. Pregnancy and lactation (for ACE inhibitors and ARBs). | ||||||||||||||||||||||||
| Drug Interactions | 1. Other Antihypertensives & Diuretics: Additive blood-pressure-lowering effects requiring monitored dose titration. 2. Potassium Supplements & Potassium-Sparing Diuretics: Elevated risk of hyperkalemia (with RAAS blockers). 3. NSAIDs: May diminish antihypertensive response and increase risk of acute renal dysfunction. |
Frequently Asked Questions
| Question | Answer |
|---|---|
| Which registration documents can be requested for Atenolol Tablets BP 50 mg? | Specify CTD/ACTD, COPP, FSC, COA and stability requirements for availability review. |
| Is Zone IVb data available for Atenolol Tablets BP 50 mg? | Request confirmation for the exact formulation and packaging configuration. |
| Can export artwork be multilingual for Atenolol Tablets BP 50 mg? | Provide the required languages and approved regulatory artwork for review. |
| Which shipping terms can be discussed for Atenolol Tablets BP 50 mg? | EXW, FOB, CIF and CIP may be evaluated according to shipment mode and agreement. |
| How do I obtain an export quotation for Atenolol Tablets BP 50 mg? | Provide destination country, quantity, documentation requirements and preferred trade terms. |
Related Products
✚
Atenolol Tablets BP 100 mg ExporterView product →
✚
Atenolol Tablets BP 100 mg ManufacturerView product →
✚
Atenolol Tablets BP 100 mg SupplierView product →
✚
Atenolol Tablets BP 50 mg ManufacturerView product →
✚
Atenolol Tablets BP 50 mg SupplierView product →
✚
Atenolol Tablets IP 100 mg ExporterView product →
✚
Atenolol Tablets IP 100 mg ManufacturerView product →
✚
Atenolol Tablets IP 100 mg SupplierView product →
✚
Atenolol Tablets IP 25 mg ExporterView product →
✚
Atenolol Tablets IP 25 mg ManufacturerView product →
✚
Atenolol Tablets IP 25 mg SupplierView product →
✚
Atenolol Tablets IP 50 mg ExporterView product →
